This prospective randomized multicenter trial shows the benefits of performing mpMRI of the prostate as a first step in the management of biopsy naïve patients with clinically suspected prostate cancer.

Kasivisvanathan V. and PRECISION Study Group Collaborators. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med. 2018 Mar 18. doi: 10.1056/NEJMoa1801993. [Epub ahead of print] PubMed PMID: 29552975.